[en] Isochromosome of the long arm of chromosome 20 with interstitial loss of material [ider(20q)] is a rare cytogenetic abnormality reported in myelodysplastic syndrome (MDS), with neither specific morphological pattern nor clear prognostic significance. The aim of this retrospective multicentric study is to compare the peripheral blood and bone marrow morphology of MDS patients with ider(20q) (n = 13) and del(20q) (n = 21) and controls (n = 47) in order to investigate whether the ider(20q) harbors specific morphological features. The secondary objective is to compare the outcome of patients from both groups. This study performed on the largest cohort of MDS patients with ider(20q) is the first that identifies specific morphological features (hypogranulated and vacuolized neutrophils and neutrophil erythrophagocytosis) allowing the identification of this cytogenetic abnormality with high sensitivity (70%) and specificity (85.7%). Suspected ider(20q) by morphology should therefore support targeted FISH tests in case of non informative karyotype. This combined approach will allow a better estimation of the prevalence of this underdiagnozed entity. The overall survival and progression-free survival did not statistically differ in both groups. However, hypogranulated and vacuolized neutrophils were significantly associated with survival.
Disciplines :
Genetics & genetic processes
Author, co-author :
Mullier, Francois
Daliphard, Sylvie
Garand, Richard
Dekeyser, Melanie
Cornet, Yvan
Luquet, Isabelle
Talmant, Pascaline
Richebourg, Steven
JAMAR, Mauricette ; Centre Hospitalier Universitaire de Liège - CHU > Génétique
T Li Y Xue Y Wu J Pan 2004 Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-) Br J Haematol 125 3 337 342 15086414 10.1111/j.1365-2141.2004.04921.x (Pubitemid 38621764)
N Douet-Guilbert JL Lai A Basinko N Gueganic J Andrieux B Pollet I Plantier C Delattre O Crepin S Corm MJ Le Bris F Morel M De Braekeleer 2008 Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome Br J Haematol 143 5 716 720 19036015 10.1111/j.1365-2141.2008.07436.x 1:STN:280:DC%2BD1cjmvVylug%3D%3D
AH Ligon DJ DeAngelo L Atkins P Dal Cin 2005 Isochromosome of a deleted 20q may be a relatively common abnormality in myeloid malignancies Cancer Genet Cytogenet 162 1 89 91 16157208 10.1016/j.cancergencyto.2005.02.022 1:CAS:528:DC%2BD2MXhtVWhtLnK (Pubitemid 41278478)
RN MacKinnon LJ Campbell 2005 A comparison of two contrasting recurrent isochromosomes 20 found in myelodysplastic syndromes suggests that retention of proximal 20q is a significant factor in myeloid malignancies Cancer Genet Cytogenet 163 2 176 179 16337864 10.1016/j.cancergencyto.2005.06.001 1:CAS:528:DC%2BD2MXht12qsLnL (Pubitemid 41758462)
K Saunders B Czepulkowski R Sivalingam JP Hayes M Aldouri M Sekhar M Cummins A Ho GJ Mufti 2005 Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes Cancer Genet Cytogenet 156 2 154 157 15642396 10.1016/j.cancergencyto.2004.03.018 1:CAS:528: DC%2BD2MXitFemsA%3D%3D (Pubitemid 40092354)
SA Smoley SR Fink SF Paternoster KJ Stockero LP Nguyen PL Nguyen CA Hanson GW Dewald 2007 Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q Cancer Genet Cytogenet 173 2 144 149 17321330 10.1016/j.cancergencyto.2006.11.003 1:CAS:528:DC%2BD2sXitFOgs78%3D (Pubitemid 46281353)
Y Xue Y Han T Li S Chen J Zhang J Pan Y Wu Y Wang J Shen 2010 Pulmonary alveolar proteinosis as a terminal complication in a case of myelodysplastic syndrome with idic(20q-) Acta Haematologica 123 1 55 58 19955712 10.1159/000262292
S Shetty B Roland 2008 Isoderivative chromosome 20 in bone marrow: three new cases Cancer Genet Cytogenet 184 1 72 73 18558294 10.1016/j.cancergencyto. 2008.03.003 1:CAS:528:DC%2BD1cXnt1OmtbY%3D (Pubitemid 351814969)
TH Lim AS Lim SL Tien 2006 A novel isoderivative chromosome 20 in a patient with chronic myelomonocytic leukemia Cancer Genet Cytogenet 170 1 80 82 16965963 10.1016/j.cancergencyto.2006.04.005 1:CAS:528:DC%2BD28XpsVKkt70%3D (Pubitemid 44354892)
T Li Y Xue J Zhang S Chen J Pan Y Wu Y Wang J Shen 2008 Isodicentric 20q- in two cases of b-cell acute lymphocytic leukemia with the respective t(9;20)(p11;q11.2) and t(9;22)(q34;q11.2) Cancer Genet Cytogenet 181 1 55 59 18262055 10.1016/j.cancergencyto.2007.11.003 1:CAS:528:DC%2BD1cXhvVWmsLw%3D (Pubitemid 351192038)
PJ Kurtin GW Dewald DJ Shields CA Hanson 1996 Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients Am J Clin Pathol 106 5 680 688 8929482 1:STN:280:DyaK2s%2FotlGhtg%3D%3D (Pubitemid 26392776)
Swerdlow S, Campo E, Harris N-L, Jaffe E-S, Pileri S-A, Stein H, Thiele J, Vardiman J-W (2008) Who classification of tumours of haematopoietic and lymphoid tissues. First published, Lyon
M Hur KM Lee HC Cho YI Park SH Kim YW Chang YR Kim HI Cho 2004 Protein 4.1 deficiency and deletion of chromosome 20q are associated with acquired elliptocytosis in myelodysplastic syndrome Clin Lab Haematol 26 1 69 72 14738441 10.1111/j.0141-9854.2003.00583.x 1:STN:280:DC%2BD2c%2Fpt1SqsQ%3D%3D (Pubitemid 38241484)
F Ishida S Shimodaira H Kobayashi H Saito M Kaku A Kanzaki Y Yawata K Kitano K Kiyosawa 1999 Elliptocytosis in myelodysplastic syndrome associated with translocation (1;5)(p10;q10) and deletion of 20q Cancer Genet Cytogenet 108 2 162 165 9973947 10.1016/S0165-4608(98)00135-6 1:CAS:528:DyaK1MXktlCntw%3D%3D (Pubitemid 29021963)
J Brezinova Z Zemanova S Ransdorfova L Sindelarova M Siskova R Neuwirtova J Cermak K Michalova 2005 Prognostic significance of del(20q) in patients with hematological malignancies Cancer Genet Cytogenet 160 2 188 192 15993278 10.1016/j.cancergencyto.2004.12.019 1:CAS:528:DC%2BD2MXlvVWnsrY%3D (Pubitemid 40910057)
LJ Campbell OM Garson 1994 The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders Leukemia 8 1 67 71 8289501 1:STN:280:DyaK2c7hvVGlsQ%3D%3D (Pubitemid 24032821)
P Greenberg C Cox MM LeBeau P Fenaux P Morel G Sanz M Sanz T Vallespi T Hamblin D Oscier K Ohyashiki K Toyama C Aul G Mufti J Bennett 1997 International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 6 2079 2088 9058730 1:CAS:528:DyaK2sXhvVars70%3D (Pubitemid 27132124)
YC Liu Y Ito HH Hsiao G Sashida A Kodama JH Ohyashiki K Ohyashiki 2006 Risk factor analysis in myelodysplastic syndrome patients with del(20q): prognosis revisited Cancer Genet Cytogenet 171 1 9 16 17074585 10.1016/j.cancergencyto.2006.06.003 1:CAS:528:DC%2BD28XhtFequrbE (Pubitemid 44635745)
D Haase 2008 Cytogenetic features in myelodysplastic syndromes Ann Hematol 87 7 515 526 18414863 10.1007/s00277-008-0483-y
D Haase U Germing J Schanz M Pfeilstocker T Nosslinger B Hildebrandt A Kundgen M Lubbert R Kunzmann AA Giagounidis C Aul L Trumper O Krieger R Stauder TH Muller F Wimazal P Valent C Fonatsch C Steidl 2007 New insights into the prognostic impact of the karyotype in mds and correlation with subtypes: evidence from a core dataset of 2124 patients Blood 110 13 4385 4395 17726160 10.1182/blood-2007-03-082404 1:CAS:528:DC%2BD1cXot1Sq (Pubitemid 351377805)
T Li Y Xue Y Wu J Pan 2006 Fish studies identify the i(20q-) anomaly as a der(20)del(20)(q11q13)idic(20)(p11) Genes Chromosomes Cancer 45 6 536 539 16506189 10.1002/gcc.20313 1:CAS:528:DC%2BD28XktlCrur4%3D (Pubitemid 43727160)
FA Asimakopoulos AR Green 1996 Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders Br J Haematol 95 2 219 226 8904873 10.1046/j.1365-2141.1996.d01-1896.x 1:STN:280:DyaK2s%2FmtVyhtQ%3D%3D (Pubitemid 26360206)
E Wattel JL Lai M Hebbar C Preudhomme D Grahek P Morel F Bauters P Fenaux 1993 De novo myelodysplastic syndrome (mds) with deletion of the long arm of chromosome 20: a subtype of mds with distinct hematological and prognostic features? Leuk Res 17 11 921 926 8231232 10.1016/0145-2126(93)90038-M 1:STN:280:DyaK2c%2FkvVWquw%3D%3D (Pubitemid 23330143)
P Valent HP Horny 2009 Minimal diagnostic criteria for myelodysplastic syndromes and separation from icus and idus: update and open questions Eur J Clin Invest 39 7 548 553 19453651 10.1111/j.1365-2362.2009.02151.x 1:STN:280:DC%2BD1MvjsFSjsA%3D%3D
JF Lesesve R Garand 2009 Evaluation of a telemedicine system for the transmission of morpho/immunological data aiming at the inclusion of patients in a therapeutic trial Intern J Telemed Appl 2009 767145
Shaffer LG, Clovak ML, Campbell LJ (eds) (2009) An International System for Human Cytogenetic Nomenclature (ISCN) (2009). Karger, Basel
N Douet-Guilbert J Andrieux JL Lai P Morice JL Demory A Basinko V Ugo N Gueganic MJ Le Bris F Morel M De Braekeleer 2009 Isoderivative of deleted chromosome 20 in primary myelofibrosis (pmf) characterized by molecular cytogenetics and array cgh Ann Hematol 88 11 1157 1159 19444446 10.1007/s00277-009-0753-3 1:STN:280:DC%2BD1MnislCmuw%3D%3D
Bain B (2006) Disorders of white cells. In: Blood cells-a practical guide. Blackwell, Oxford, UK, p 398
CH Mermel ML McLemore F Liu S Pereira J Woloszynek CA Lowell DC Link 2006 Src family kinases are important negative regulators of g-csf-dependent granulopoiesis Blood 108 8 2562 2568 16772601 10.1182/blood-2006-05-024307 1:CAS:528:DC%2BD28XhtFWgtL7M
S Ascani E Sabattini C Agostinelli PP Piccaluga PL Zinzani SA Pileri 2004 Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome Haematologica 89 4 EIM07 15075110
H Mori M Tawara Y Yoshida K Kuriyama K Sugahara S Kamihira M Tomonaga 2000 Minimally differentiated acute myeloid leukemia (aml-m0) with extensive erythrophagocytosis and del(20)(q11) chromosome abnormality Leuk Res 24 1 87 90 10634652 10.1016/S0145-2126(99)00145-9 1:STN:280:DC%2BD3c%2FpvVWnsg%3D%3D
J Etzell CM Lu LW Browne E Wang 2005 Erythrophagocytosis by dysplastic neutrophils in chronic myelomonocytic leukemia and subsequent transformation to acute myeloid leukemia Am J Hematol 79 4 340 342 16044446 10.1002/ajh.20392 (Pubitemid 41098854)
J Kuyama M Fushino H Take Y Kanayama 1995 Myelodysplastic syndrome associated with erythrophagocytosis by blasts and myeloid cells Int J Hematol 62 4 243 246 8589370 10.1016/0925-5710(95)00409-2 1:STN:280:DyaK287ls1yqsA%3D%3D (Pubitemid 26006380)
S Moretti F Lanza S Spisani A Latorraca GM Rigolin AL Giuliani GL Castoldi S Traniello 1994 Neutrophils from patients with myelodysplastic syndromes: relationship between impairment of granular contents, complement receptors, functional activities and disease status Leuk Lymphoma 13 5-6 471 477 8069192 10.3109/10428199409049637 1:STN:280:DyaK2czkvVertA%3D%3D (Pubitemid 24158968)
A Ohsaka K Saionji J Igari N Watanabe K Iwabuchi I Nagaoka 1997 Altered surface expression of effector cell molecules on neutrophils in myelodysplastic syndromes Br J Haematol 98 1 108 113 9233572 10.1046/j.1365-2141.1997.1873007.x 1:STN:280:DyaK2szns1yjsw%3D%3D (Pubitemid 27348803)
X An N Mohandas 2008 Disorders of red cell membrane Br J Haematol 141 3 367 375 18341630 1:CAS:528:DC%2BD1cXmt1ait7s%3D (Pubitemid 351521152)
N Douet-Guilbert A Basinko F Morel MJ Le Bris V Ugo P Morice C Berthou M De Braekeleer 2008 Chromosome 20 deletions in myelodysplastic syndromes and philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions Ann Hematol 87 7 537 544 18350294 10.1007/s00277-008-0462-3 1:CAS:528:DC%2BD1cXmt12rurc%3D
CP Soupir JA Vergilio E Kelly P Dal Cin D Kuter RP Hasserjian 2009 Identification of del(20q) in a subset of patients diagnosed with idiopathic thrombocytopenic purpura Br J Haematol 144 5 800 802 19055669 10.1111/j.1365-2141.2008.07508.x
M Voulgarelis S Giannouli K Ritis AG Tzioufas 2004 Myelodysplasia- associated autoimmunity: clinical and pathophysiologic concepts Eur J Clin Invest 34 10 690 700 15473894 10.1111/j.1365-2362.2004.01417.x 1:STN:280:DC%2BD2crgsFOisQ%3D%3D (Pubitemid 39423027)
